Kebede Molla Asnake, Mengistu Yewondwosen Tadesse, Loge Biruk Yacob, Eshetu Misikr Alemu, Shash Erkihun Pawlos, Wirtu Amenu Tolera, Gemechu Jickssa Mulissa
Department of Internal Medicine, School of Medicine, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman P.O. Box 260, Ethiopia.
Department of Nephrology, College of Health Sciences, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia.
J Pers Med. 2024 Sep 2;14(9):936. doi: 10.3390/jpm14090936.
Despite its severity, there has been a lack of adequate study on autosomal dominant polycystic kidney disease (ADPKD) in Ethiopia. This study assessed the clinical profile and determinant factors contributing to renal disease progression.
A retrospective study was conducted on 114 patients for 6 years in Addis Ababa. Patients with ADPKD who had follow-up visits at two health centers were included.
The mean age at diagnosis was 42.7 ± 12.7 years, with 43% reporting a positive family history of ADPKD. Approximately 22 patients (20%) developed end-stage renal disease, and 12 patients died. The mean estimated glomerular filtration rate at the initial visit was 72.4 mL/min/1.73 m. The key risk factors associated with disease progression included younger age at diagnosis [adjusted Odds Ratio (aOR): 0.92, 95% CI: 0.87-0.98; = 0.007], male gender (aOR: 4.5, 95% CI: 1.3-15.95, = 0.017), higher baseline systolic blood pressure (aOR: 1.05, 95% CI: 1.01-1.10, = 0.026), and the presence of comorbidities (aOR: 3.95, 95% CI: 1.10-14.33, = 0.037). The progression of renal disease in ADPKD patients significantly correlates with age at diagnosis, gender, presence of comorbidities, and higher baseline systolic blood pressure.
These findings underscore the importance of early detection and management of hypertension and comorbidities in ADPKD patients to mitigate disease progression and improve treatment outcomes.
尽管常染色体显性遗传性多囊肾病(ADPKD)病情严重,但埃塞俄比亚对其缺乏充分研究。本研究评估了ADPKD的临床特征及导致肾病进展的决定因素。
在亚的斯亚贝巴对114例患者进行了为期6年的回顾性研究。纳入在两个健康中心接受随访的ADPKD患者。
诊断时的平均年龄为42.7±12.7岁,43%的患者报告有ADPKD家族史阳性。约22例患者(20%)发展为终末期肾病,12例患者死亡。初次就诊时的平均估计肾小球滤过率为72.4 mL/min/1.73 m²。与疾病进展相关的关键危险因素包括诊断时年龄较小[调整后优势比(aOR):0.92,95%置信区间(CI):0.87 - 0.98;P = 0.007]、男性(aOR:4.5,95% CI:1.3 - 15.95,P = 0.017)、较高的基线收缩压(aOR:1.05,95% CI:1.01 - 1.10,P = 0.026)以及合并症的存在(aOR:3.95,95% CI:1.10 - 14.33,P = 0.037)。ADPKD患者的肾病进展与诊断时年龄、性别、合并症的存在以及较高的基线收缩压显著相关。
这些发现强调了在ADPKD患者中早期检测和管理高血压及合并症对于减轻疾病进展和改善治疗结果的重要性。